Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy
- 1 June 2002
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 8 (3) , 200-206
- https://doi.org/10.1191/1352458502ms802oa
Abstract
We used quantitative magnetic resonance (MR) spectroscopic imaging with T1-based image segmentation to evaluate the subtypes of multiple sclerosis (MS) (eight patients each group of relapsing-remitting [RR], secondary progressive [SP] and primary progressive [PP]). There was no significant difference in age between the PP group with the RR, SP or control group. We found that the metabolite ratio of choline/NA from the periventricular white matter region was not significantly different between the RR and SP groups. Using an ANOVA, the ratios of periventricular choline/NA or creatine/NA of these combined groups were significantly higher than the PP and control groups. Quantification of these data suggest that the major cause of the elevation of these parameters is due to an increase in choline and creatine in the RR group while NA is decreased in the SP group. Thus, early PP disease appears to be relatively intact with respect to neuronal loss.Keywords
This publication has 25 references indexed in Scilit:
- In Vitro Expression of N‐Acetyl Aspartate by OligodendrocytesJournal of Neurochemistry, 2000
- 1 H Magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosisZeitschrift für Neurologie, 1999
- The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessmentMultiple Sclerosis Journal, 1999
- N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial DysfunctionDevelopmental Neuroscience, 1998
- Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosisAnnals of Neurology, 1998
- 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesionsAnnals of Neurology, 1997
- Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 TMagnetic Resonance in Medicine, 1996
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodiesNeuroscience, 1991